ConductScience.org, home

Paper36930674

Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis.

COVID-19 Forecasting Team. Lancet, 2023. Cited by 318 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis. Papers, record 36930674. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36930674

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis.
PubMed
Journal
Lancet
PubMed
Year
2023
PubMed
Publication types
Meta-Analysis, Systematic Review, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
318
iCite
Relative citation ratio, by iCite
25.8
iCite
Revised in PubMed
2026-05-18
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1COVID-19 Forecasting TeamGroup

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
COVID-19Major topic
United States
Humans
Bayes Theorem
Prospective Studies
Reinfection
Retrospective Studies
SARS-CoV-2

Source PubMed

Comments and corrections3

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in36,930,672COVID-19 infection, reinfection, and the transition to endemicity.https://conductscience.org/library/papers/36930672PubMed
Comment in37,777,328Extra data to confirm waning protection of omicron (B.1.1.529) natural immunity.https://conductscience.org/library/papers/37777328PubMed
Comment in37,777,331Natural SARS-CoV-2 infection-induced immune protection against re-infection.https://conductscience.org/library/papers/37777331PubMed

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134,043,841Quantifying the risk of SARS-CoV-2 reinfection over time.Rev Med Virol2022https://conductscience.org/library/papers/34043841PubMed
232,668,444SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.Nature2020https://conductscience.org/library/papers/32668444PubMed
334,592,838A Systematic Review of the Protective Effect of Prior SARS-CoV-2 Infection on Repeat Infection.Eval Health Prof2021https://conductscience.org/library/papers/34592838PubMed
433,686,204A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker).Nat Hum Behav2021https://conductscience.org/library/papers/33686204PubMed
533,450,303Prior COVID-19 significantly reduces the risk of subsequent infection, but reinfections are seen after eight months.J Infect2021https://conductscience.org/library/papers/33450303PubMed
634,908,003Reinfection rates among patients previously infected by SARS-CoV-2: systematic review and meta-analysis.Chin Med J (Engl)2022https://conductscience.org/library/papers/34908003PubMed
735,945,213Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage.Nat Commun2022https://conductscience.org/library/papers/35945213PubMed
834,954,658Mucosal immune response in BNT162b2 COVID-19 vaccine recipients.EBioMedicine2022https://conductscience.org/library/papers/34954658PubMed
932,434,945DNA vaccine protection against SARS-CoV-2 in rhesus macaques.Science2020https://conductscience.org/library/papers/32434945PubMed
1032,943,637A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity.Nat Commun2020https://conductscience.org/library/papers/32943637PubMed
1135,279,232Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.Lancet2022https://conductscience.org/library/papers/35279232PubMed
1232,955,556Pandemic Politics: Timing State-Level Social Distancing Responses to COVID-19.J Health Polit Policy Law2021https://conductscience.org/library/papers/32955556PubMed
1335,133,177Rapid increase in Omicron infections in England during December 2021: REACT-1 study.Science2022https://conductscience.org/library/papers/35133177PubMed
1435,149,106SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity.Environ Res2022https://conductscience.org/library/papers/35149106PubMed
1533,140,086Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients.J Infect Dis2021https://conductscience.org/library/papers/33140086PubMed
1635,961,956Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections.Nat Commun2022https://conductscience.org/library/papers/35961956PubMed
1736,198,139Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants.N Engl J Med2022https://conductscience.org/library/papers/36198139PubMed
1836,152,671
Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study.
Lancet Infect Dis2023https://conductscience.org/library/papers/36152671PubMed
1934,914,115Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.J Med Virol2022https://conductscience.org/library/papers/34914115PubMed
2033,493,185T cell response to SARS-CoV-2 infection in humans: A systematic review.PLoS One2021https://conductscience.org/library/papers/33493185PubMed

See all 39 references

Cited by246

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 318 citations.

PMIDTitleJournalYearIn PapersSource
42,818,453Longitudinal antibody correlates of SARS-CoV-2 infection in a US household cohort during Omicron waves.medRxiv2026https://conductscience.org/library/papers/42818453PubMed
42,811,742Real-world evaluation of 2023-2024 XBB.1.5 mRNA and protein-based COVID-19 vaccine reactogenicity from the randomized BEEHIVE trial.Hum Vaccin Immunother2026https://conductscience.org/library/papers/42811742PubMed
42,745,337Travel vaccination in senior travelers: current evidence, challenges, and prevention.Trop Dis Travel Med Vaccines2026https://conductscience.org/library/papers/42745337PubMed
42,442,743Reassessing Early COVID-19 Strategies in East Asia: Insights From Japan and Korea.J Prev Med Public Health2026https://conductscience.org/library/papers/42442743PubMed
42,369,736Assessing risk of COVID-19 reinfection and complications in adults treated with stimulant medications: A retrospective study using electronic health records.Med Res Arch2024https://conductscience.org/library/papers/42369736PubMed
42,347,641Characteristics of SARS-CoV-2 Reinfection and Ancestral RBD-Blocking Antibody Levels: A Cross-Sectional Study in the Post-Zero-COVID Era from Shanghai.Vaccines (Basel)2026https://conductscience.org/library/papers/42347641PubMed
42,188,767Hybrid and Vaccine-Induced Immunity Against SARS-CoV-2 in a Cohort of Hospitalized Patients from the Metropolitan Aburrá Valley, Colombia.Vaccines (Basel)2026https://conductscience.org/library/papers/42188767PubMed
42,173,827SARS-CoV-2 infection and vaccination elicit distinct pharyngeal mucosal B cell responses in children.Nat Commun2026https://conductscience.org/library/papers/42173827PubMed
42,129,996
How does prior infection and vaccination relate to the risk of incident SARS-CoV-2 infection/reinfection? A prospective cohort study among nine clinical sites in the USA, February 2021 to January 2023.
BMJ Open2026https://conductscience.org/library/papers/42129996PubMed
42,094,075Epidemiological Trends of COVID-19 Infection and Symptom Incidence in China Following the Adjustment of Zero-COVID Policy: A Prospective, Community-Based Cohort Study.Transbound Emerg Dis2026https://conductscience.org/library/papers/42094075PubMed
41,812,140Prevalence and Factors Associated With Acute Stress Disorder Among Adults Ever Infected With COVID-19 During the Ending Phase of the Pandemic in 7 Chinese Cities: Cross-Sectional Study.JMIR Public Health Surveill2026https://conductscience.org/library/papers/41812140PubMed
41,803,122Infection-acquired protection against SARS-CoV-2 infection and clinical severity by number of prior infections.Nat Commun2026https://conductscience.org/library/papers/41803122PubMed
41,746,093Challenges and Prospects in the Development of a Universal SARS-CoV-2 Vaccine.Vaccines (Basel)2026https://conductscience.org/library/papers/41746093PubMed
41,746,085A Reanalysis of the FDA's Benefit-Risk Assessment of Moderna's mRNA-1273 COVID Vaccine Based on a Model Incorporating Benefits Derived from Prior COVID Infection.Vaccines (Basel)2026https://conductscience.org/library/papers/41746085PubMed
41,613,763Natural Selection-Guided ACE2-Targeted Molecular Imaging: A New Paradigm for PET Tracer Development.Chem Biomed Imaging2026https://conductscience.org/library/papers/41613763PubMed
41,527,184Early COVID-19 and Severity of Subsequent Omicron Infection in Ontario Canada.Influenza Other Respir Viruses2026https://conductscience.org/library/papers/41527184PubMed
41,466,249Hybrid, infection- and vaccination-induced protection against laboratory- confirmed SARS-CoV-2 infection in a European multi-centre prospective cohort of healthcare workers, 2021-2024.BMC Med2025https://conductscience.org/library/papers/41466249PubMed
41,347,851Assessing SARS-CoV-2 transmission in African households from the reanalysis of serosurveys.Am J Epidemiol2026https://conductscience.org/library/papers/41347851PubMed
41,332,493[The Suspected Coronavirus Disease 2019 Reinfection Cases and Vaccine Effectiveness, The Republic of Korea].Jugan Geongang Gwa Jilbyeong2023https://conductscience.org/library/papers/41332493PubMed
41,272,190Humoral immunity and clinical characteristics of Chinese college students experiencing a BA.5/BF.7 and XBB.1.5 wave.Sci Rep2025https://conductscience.org/library/papers/41272190PubMed

See all 246 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
NFKB14,790PubTator's text mininghttps://conductscience.org/library/genes/4790

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36930674

GET https://conductscience.org/api/papers/v1/36930674/references?page=2